Delivery Order SPE2DB22D3016-SPE2DB25FBFQ9
- Not listed
- The Defense Logistics Agency awarded a $1,212.30 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xhance 93 mcg nasal spray (16 mL). This firm fixed-price delivery order, which must be completed by August 11, 2025, represents a routine pharmaceutical procurement under the company's existing contract vehicle. The award was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $3,086.89 firm-fixed-price delivery order is for the supply of XHANCE 93 MCG Nasal Spray 16ML, with a period of performance through August 23, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,260.72, is for the delivery of the pharmaceutical product XHANCE 93 MCG NASAL SPRAY 16ML. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $583 to Amerisourcebergen Drug Corporation for XHANCE 93 mcg nasal spray. The prime contractor will deliver 16mL bottles of the nasal spray to a location in Conshohocken, Pennsylvania by August 1, 2023 in support of DLA programs. Amerisourcebergen will perform the order itself, as no subcontractors were identified. The Defense Logistics Agency manages the global supply chain for the U.S. military and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XHANCE 93 MCG Nasal Spray 16ML. The $4,796.97 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a wide range of medical commodities to support military treatment programs...
- This contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,770.87 firm fixed-price delivery order is for the drug product XHANCE 93 MCG Nasal Spray, 16 mL. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,329.80, is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML. This is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,203.10 and a period of performance ending on July 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $5,781.06 firm fixed price delivery order is for the supply of the pharmaceutical product XHANCE 93 MCG Nasal Spray 16ML. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) from DLA with a potential value of $999,999,999.00 and a performance period...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,755.30, is for the delivery of the drug XHANCE 93 MCG NASAL SPRAY 16ML. The contract is a firm-fixed-price, Indefinite Delivery Contract (IDC) that runs through February 12, 2025. This IDC, valued at $999,999,999, serves as a primary vehicle for providing a...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBFQ9Delivery Order
The Defense Logistics Agency awarded a $4,033.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XHANCE 93 micrograms nasal spray (16 milliliters) on August 20, 2025, with completion scheduled for August 21, 2025. This non-set-aside award was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order represents a routine pharmaceutical procurement from the prime contractor's comprehensive global pharmaceutical support vehicle, which enables supply of medications, vaccines, and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical vendor. The company maintains extensive experience fulfilling DLA requirements through competitively awarded delivery orders across diverse pharmaceutical categories, including specialty medications and branded drugs. This delivery order for XHANCE nasal spray reflects the company's ongoing role as a primary pharmaceutical supplier supporting the Defense Health Agency and other federal healthcare systems through the DLA's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/20/25 |